HOME >> BIOLOGY >> NEWS
Epigenetic studies will provide a better understanding of disease

From 26-28 March, the Institute for Research in Biomedicine (IRB Barcelona) will bring together 20 internationally recognised scientists from the USA and Europe working in epigenetics to present their latest work. Invited by Ferran Azorn, principal investigator at IRB Barcelona, and Tony Kouzarides, director of the Gurdon Institute in the United Kingdom, these scientists will participate in a new Barcelona BioMed Conference, one of a series organised jointly by IRB Barcelona and the BBVA Foundation. The conference will be held in the Auditorium (Tower D) of the Barcelona Science Park.

Epigenetics emerged on the scene in the 1990s. Researchers discovered that chromatin, the complex formed by DNA and histones, -proteins that bind strongly to DNA, thereby packaging it in chromosomes-, regulate gene expression. This additional layer of regulatory instructions, which are not held in DNA, comprise the epigenetic code.

Epigenetic differences explain, for example, why two cloned organisms are not the same or why twins develop illnesses of distinct genetic origin. Epigenetic studies promise not only to have a direct impact on health and our understanding of the relations between the environment and genetics but also to provide an explanation of basic aspects of cell biology. The co-organiser of the conference, Ferran Azorn, head of the "Chromatin Structure and Function" group at IRB Barcelona, comments that "deciphering and understanding the epigenome will shed light on fundamental processes in cell physiology. This knowledge will improve our understanding of the development of tumours and other diseases, and may lead to the design of new treatments for these conditions". A new family of epigenetic drugs, designed to reverse the changes in the epigenome that occur during the development of several kinds of cancer, is currently available. Several of these pharmacological agents are now being used to treat some types of leukaemia and breast cancer.


'"/>

Contact: Snia Armengou
sarmengou@pcb.ub.es
34-934-037-255
Institute for Research in Biomedicine (IRB)
19-Mar-2007


Page: 1 2

Related biology news :

1. Epigenetics to shape stem cell future
2. Epigenetic drugs, promising for breast cancer treatment
3. New view of cancer: Epigenetic changes come before mutations
4. Epigenetic activity silences Rb2/P130 gene in lung cancer
5. New studies on goats milk show it is more beneficial to health than cows milk
6. Berkeley Lab Life Sciences division awarded NIH grants for fruit fly, nematode studies
7. Obtaining valid consent for doing large genetic studies in developing countries
8. Short-term studies suggest that whole grain oats may reduce risk factors for coronary heart disease
9. New studies link the environment to Parkinsons disease
10. Ewwwww! UCLA anthropologist studies evolutions disgusting side
11. Genetic studies endow mice with new color vision

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... Report on Form 10-K on Thursday April 13, 2017 with the ... The ... section of the Company,s website at http://www.nxt-id.com  under "SEC Filings," ... 2016 Year Highlights: Acquisition of ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... Rosalind™, the first-ever genomics analysis platform specifically designed for life science researchers ... honor of pioneering researcher Rosalind Franklin, who made a major contribution to ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia ... be hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” ... pathology adoption best practices and how Proscia improves lab economics and realizes an ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... 2017 International research firm Parks Associates announced today ... the TMA 2017 Annual Meeting , October 11 in ... home security market and how smart safety and security products impact the ... Parks Associates: Smart Home Devices: ... "The residential security market has experienced ...
Breaking Biology Technology:
Cached News: